Pharmaceutical Business review

Orthofix signs license agreement with TSRHC

True/Lok is a versatile, lightweight system designed to correct limb deformities, treat bone fractures and lengthen limbs using a simpler frame, according to Orthofix International.

In addition to marketing the current True/Lok system, the arrangement provides for Texas Scottish Rite Hospital for Children (TSRHC) and Orthofix to collaborate in the development and marketing of future versions of the True/Lok system introduced to the medical community during the term of the agreement.

Alan Milinazzo, CEO of Orthofix International, said: “This agreement demonstrates the company’s commitment to maintain its role as a significant participant in the global orthopedic fixation market. This collaboration is an important example of our ongoing focus on the development of innovative, minimally invasive treatments around the world.”